A clinical trial to study effect of Avipattikar Choorna, Samasharkara Choorna and Agastya Haritaki Avaleha in the management of Chronic Cough with Gastroesophageal reflux disease.

Efficacy of Avipattikar Choorna, Samasharkara Choorna along with Agastya Haritaki Avaleha in the management of Pitta-Pradhana Kapha Anubandhi Kasa with special reference to Chronic Cough with Gastroesophageal reflux disease - A single-arm open-labeled clinical trial.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/04/051452

Enrollment

Registered

2023-04-10

Start date

Unknown

Completion date

Unknown

Last updated

2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R05- Cough

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: i.Cough > 8 weeks. ii.Age group:- 18-60 yrs. iii.Patients with symptoms of Pitta Pradhana Kapha-Anubandhi Kasa as mentioned in diagnostic criteria with cardinal symptoms like Kasa; Ghan Snigdha Shweta Shleshma; Pitta Sansrushta Kapha Shthivan; Vaiswarya and also with the symptoms of gastroesophageal reflux disease in any of its criteria; i.e. Acid Reflux, dysmotility symptoms, as per FSSG scale (Mentioned in ANNEXURE 2).

Exclusion criteria

Exclusion criteria: i.Patients currently taking bronchodilators; Nebulization, or anti-histamines. ii.Patients with Co-morbidities–Stage II HTN (Systolic BP above 160mmHg and Diastolic BP above 100mmHg), known case of Cardiovascular disease, Known case of DM-Type II. iii.Patients with cough due to Respiratory muscle depression. iv.Patients with a known case of infective pathology related to the respiratory system. v.Patients with any other alimentary system pathology other than GERD and these pathologies will be ruled out by USG in concerned subjects having classical symptoms of the disease.

Design outcomes

Primary

Measure	Time frame
To provide symptomatic improvement in patients of Chronic Cough with Gastroesophageal reflux disease.Timepoint: On Day 0 and Day 50	—

Secondary

Measure	Time frame
To improve the quality of life of patients with Chronic cough with special reference to GERD.Timepoint: On Day 0 and Day 50	—

Countries

India

Contacts

Public ContactNachiket Dixit

I.T.R.A. Jamnagar

mandipgoyal22@gmail.com9427572306

Outcome results